Patients should get a standard set of labs and PSA to check for recurrence of prostate cancer as well as inflammatory markers such as the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) along with the white blood cell (WBC) count. Here, CRP is linked to prostate carcinoma.